NEWS
Mesoblast eyes COVID-19 trial results by end of year
MELBOURNE: Stem cell biotech Mesoblast believes it will know how effective its potential COVID-19 treatment… read more
Voltaren manufacturers fined $4.5m for misleading consumers
MELBOURNE: The makers of Voltaren pain gels have been fined $4.5 million for falsely passing… read more
Seniors housing and care need fundamental rethink
MELBOURNE: The founder of an influential care organisation believes seniors and disability care needs a… read more
Elective surgery services increasing in ‘safest way possible’
HOBART: Elective surgery levels in Tasmania are continuing to be lifted in line with staged… read more
